Simple Summary Rosai–Dorfman disease (RDD) was a benign histiocytic proliferative
disorder rather than a neoplastic process. Emergent molecular studies have shown …

Case 30-2024: A 45-Year-Old Woman with Kidney Lesions and Lytic Bone Disease | New
England Journal of Medicine Skip to main content The New England Journal of Medicine …

Pediatric cancer, although rare, requires the most optimized treatment approach to obtain
high survival rates and minimize serious long-term side effects in early adulthood. 18F-FDG …

Little is known about outcomes following interruption of targeted therapy in adult patients
with histiocytic neoplasms. This is an IRB‐approved study of patients with histiocytic …

Erdheim-Chester disease is a rare non-Langerhans cell histiocytosis. The disease is widely
variable in its severity, ranging from incidental findings in asymptomatic patients to a fatal …

Purpose To evaluate the clinical presentation, treatment, and outcomes in adult patients with
histiocytic disorders with ocular, orbital, optic nerve, or cavernous sinus involvement. Design …

Objectives To present 4 patients with Erdheim-Chester disease (ECD) based on clinical,
radiologic, histopathologic, and molecular genetic findings who had enhancing brainstem …

Histiocytic sarcoma (HS) is a rare hematological malignancy with limited treatment options,
and it is also prone to complications such as hemophagocytic lymphohistiocytosis (HLH) in …

Histiocytoses encompass a group of exceptionally rare disorders characterized by the
abnormal infiltration of tissues by histocytes. Among these, Erdheim–Chester disease (ECD) …

Abstract Purpose of Review Histiocytic disorders, including Erdheim-Chester disease (ECD),
Langerhans cell histiocytosis (LCH), and Rosai-Dorfman disease (RDD), are rare …